Post-glycosylphosphatidylinositol (GPI) attachment to proteins 3, also known as PGAP3 or PERLD1 (PER1-like domain-containing protein 1), participates in the lipid remodeling process of glycosylphosphatidylinositol (GPI) anchor proteins during post-translational modification. Functional defect in PERLD1 was previously hypothesized to influence this process in T-cells and their subsequent activation and proliferation. This current study aims to functionally characterize PERLD1 genetic variants and relate this with human immune cells proliferation rate upon stimulation. We first showed the association between a PERLD1 tag-single nucleotide polymorphism (tagSNP), rs2941504, and the development of asthma in our study population. This association remained significant after conditioning for the other asthma-associated SNP rs8076131 that is also located within the 17q12-21 region. Subsequent sequencing of 40 unrelated Singapore Chinese individuals identified 12 more common PERLD1 SNPs (minor allele frequency > 5%) that are in linkage disequilibrium (LD, r > 0.8) with rs2941504. Through in vitro studies, 7 of these SNPs were found to form a functional haplotype that influences alternative splicing of PERLD1 transcript. This result was validated in human peripheral blood mononuclear cell (PBMC), where the minor haplotype (Hap2) was shown to be associated with significantly increased PERLD1 truncated transcript. Additionally, Hap2 was found to be related to increased levels of several soluble GPI-anchored proteins (such as sCD55 and sCD59) in serum. Elevated sCD55 in the serum was demonstrated to reduce the proliferation rate of PBMCs upon phytohaemagglutinin (PHA) stimulation. Taken together, the current study has shown a functional PERLD1 haplotype, which modifies PBMC sensitivity upon stimulation and may contribute to the individual's susceptibility to allergic asthma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970992PMC
http://dx.doi.org/10.1038/s41598-020-57592-9DOI Listing

Publication Analysis

Top Keywords

perld1
9
per1-like domain-containing
8
domain-containing protein
8
perld1 haplotype
8
haplotype influences
8
current study
8
proliferation rate
8
asthma-associated per1-like
4
protein perld1
4
haplotype
4

Similar Publications

Post-glycosylphosphatidylinositol (GPI) attachment to proteins 3, also known as PGAP3 or PERLD1 (PER1-like domain-containing protein 1), participates in the lipid remodeling process of glycosylphosphatidylinositol (GPI) anchor proteins during post-translational modification. Functional defect in PERLD1 was previously hypothesized to influence this process in T-cells and their subsequent activation and proliferation. This current study aims to functionally characterize PERLD1 genetic variants and relate this with human immune cells proliferation rate upon stimulation.

View Article and Find Full Text PDF

Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.

Gene

February 2014

State Key Laboratory & Incubation Base of Dermatology of Ministry of National Science and Technology, Anhui Medical University, Hefei 230032, China.

Article Synopsis
  • The study aimed to explore the link between genetic variations (specifically SNPs) in a cluster of genes on chromosome 17q12-q21 and the risk of gastric cancer in the Chinese Han population.
  • No significant associations were found between SNPs and gastric cancer risk, but a specific haplotype (CCCT) related to the STARD3 gene appeared to offer some protective effect against the disease.
  • Additionally, the study found that STARD3 expression in gastric tissues correlated with various factors such as gender and alcohol consumption, suggesting it might play a role in the development of gastric cancer among the subjects studied.
View Article and Find Full Text PDF

The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells.

Mol Oncol

June 2013

Department of Genetics, Institute for Cancer Research, Division of Surgery and Cancer, Oslo University Hospital, Radiumhospitalet, 0310 Oslo, Norway.

About 20% of breast cancers are characterized by amplification and overexpression of the HER2 oncogene. Although significant progress has been achieved for treating such patients with HER2 inhibitor trastuzumab, more than half of the patients respond poorly or become resistant to the treatment. Since the HER2 amplicon at 17q12 contains multiple genes, we have systematically explored the role of the HER2 co-amplified genes in breast cancer cell growth and their relation to trastuzumab resistance.

View Article and Find Full Text PDF

Background: Recent genome-wide association studies (GWAS) for asthma have been successful in identifying novel associations which have been well replicated. The aim of this study is to identify the genetic variants that influence predisposition towards asthma in an ethnic Chinese population in Singapore using a GWAS approach.

Methods: A two-stage GWAS was performed in case samples with allergic asthma, and in control samples without asthma and atopy.

View Article and Find Full Text PDF

Introduction: HER2 gene amplification and protein overexpression (HER2+) define a clinically challenging subgroup of breast cancer with variable prognosis and response to therapy. Although gene expression profiling has identified an ERBB2 molecular subtype of breast cancer, it is clear that HER2+ tumors reside in all molecular subtypes and represent a genomically and biologically heterogeneous group, needed to be further characterized in large sample sets.

Methods: Genome-wide DNA copy number profiling, using bacterial artificial chromosome (BAC) array comparative genomic hybridization (aCGH), and global gene expression profiling were performed on 200 and 87 HER2+ tumors, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!